Get Your Personalized Supplement StackSupplement Stack Quiz

Total Flavone Glycosides

Also known as: Flavone glycosides, Dietary flavones, Flavonoid glycosides, Total Flavone Glycosides

Overview

Total Flavone Glycosides are a subclass of polyphenolic plant secondary metabolites, specifically flavonoids, characterized by a flavone backbone bound to sugar moieties. These compounds, such as apigenin-7-O-glucoside, are commonly found in plants like celery, parsley, and chamomile. They differ from their non-glycosylated counterparts (aglycones) in terms of solubility and bioavailability. Research primarily investigates their potential anti-inflammatory, antioxidant, and anticancer effects. While they are consumed as part of a regular diet, their use as isolated dietary supplements is an area of ongoing research. A key characteristic is that glycosylation affects their absorption and biological activity, often requiring deglycosylation in the gut for optimal effect. The research maturity is moderate, with a mix of observational studies and some controlled trials, but limited high-quality randomized controlled trials specifically on isolated total flavone glycosides.

Benefits

Total Flavone Glycosides exhibit primary anti-inflammatory activity, particularly after deglycosylation to their aglycone forms. These aglycones have been shown in vitro and in animal models to reduce pro-inflammatory markers like TNF-α and inhibit NF-κB signaling pathways. However, the strength of evidence for clinical benefits in humans is mixed. Observational meta-analyses on general dietary flavonoid intake, which includes flavone glycosides, have shown inconsistent associations with reduced risk of digestive tract cancers or cardiovascular disease, with no strong or consistent protective effect confirmed. While potential antioxidant effects and modulation of other inflammatory mediators are suggested, they are less well quantified. Evidence for population-specific benefits is lacking, with most data derived from general adult populations. The clinical relevance of observed mechanistic effects remains uncertain, as meta-analyses indicate modest or no significant risk reductions for chronic diseases.

How it works

Total Flavone Glycosides primarily exert their biological effects by modulating inflammatory pathways. Their mechanism of action involves the inhibition of pro-inflammatory cytokines, such as TNF-α, and the suppression of NF-κB transcription factor activity. These compounds interact with the immune system, particularly by influencing macrophage function. For these effects to occur, flavone glycosides often require deglycosylation by gut enzymes or microbiota. This process converts them into their aglycone forms, which are more readily absorbed and bioavailable, allowing them to interact with cellular targets and exert their anti-inflammatory and antioxidant properties within various tissues.

Side effects

Total Flavone Glycosides are generally considered safe when consumed as part of a normal diet. There are no well-documented common, uncommon, or rare side effects reported in clinical studies or reviewed literature regarding their dietary intake. However, data on high-dose supplementation is limited, and specific adverse effects in this context are not well established. There are no clearly established contraindications. While no well-established drug interactions exist, caution is advised when co-administering with anti-inflammatory or anticoagulant medications due to theoretical additive effects. Insufficient data is available regarding their safety in special populations, such as pregnant women, children, or individuals with specific health conditions.

Dosage

A minimum effective dose for isolated total flavone glycosides has not been established, and optimal dosage ranges are currently unknown. Most available data pertains to dietary intake rather than specific supplementation levels. Similarly, a maximum safe dose has not been defined. Timing considerations for supplementation are influenced by absorption factors; absorption is improved when glycosides are deglycosylated, suggesting that timing with meals might affect bioavailability. Form-specific recommendations indicate that aglycone-rich extracts generally have higher bioavailability compared to glycoside-rich forms. The critical factor for their absorption and activity is deglycosylation, which is facilitated by gut enzymes and microbiota. No specific cofactors are identified as required for their efficacy.

FAQs

Are total flavone glycosides effective anti-inflammatory agents?

Yes, primarily after deglycosylation to their aglycone forms, which have demonstrated anti-inflammatory effects in vitro and in vivo by reducing TNF-α and NF-κB signaling.

Do they reduce cancer or cardiovascular risk?

Current meta-analyses of dietary flavonoids show no strong or consistent evidence for significant cancer or cardiovascular disease risk reduction in humans.

Are supplements necessary?

Benefits from dietary sources are plausible; however, the efficacy and safety of isolated total flavone glycoside supplements require further high-quality human studies.

Is bioavailability an issue?

Yes, flavone glycosides are generally less bioavailable than their aglycone forms. Deglycosylation by gut enzymes or microbiota is crucial for their absorption and biological activity.

Research Sources

https://www.nature.com/articles/srep24836 – This meta-analysis of observational studies by Bo & Sun et al. (2016) investigated the association between dietary flavonoid intake and digestive tract cancer risk. The study found no strong association, highlighting the limitations of observational data and heterogeneity among studies.
https://pubmed.ncbi.nlm.nih.gov/23953879/ – Wang et al. (2014) conducted a systematic review and meta-analysis of prospective cohorts on flavonoid intake and cardiovascular disease risk. While some modest reductions were noted, the results were inconsistent across studies, indicating potential confounders and the observational nature of the data.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4070292/ – Chen et al. (2014) performed in vitro and animal studies demonstrating that deglycosylation increases flavone absorption and anti-inflammatory activity by reducing TNF-α and NF-κB. This high-quality mechanistic study provides insight into the biological pathways but requires confirmation of translational relevance to humans.